Specialty Pharmacy News | Specialty Pharmacy Industry | Avella Blog

Avella Specialty Pharmacy

How to Achieve Environmental Sustainability in the Healthcare Industry

Today marks the 45th anniversary of the first Earth Day celebration, which is held annually on April 22nd to help demonstrate worldwide support for environmental sustainability. Environmental sustainability plays an important role in the healthcare ...

Mon, Apr 6, 2015

Janedu: New FDA-Approved Drug to Treat Chronic Iron Overload

Novartis announced this week that the US Food and Drug Administration has approved Jadenu™ (deferasirox) tablets. Jadenu is a new oral tablet for the treatment of chronic iron overload. Chronic iron overload can occur due to blood transfusions in ...

Mon, Mar 23, 2015

The Importance of Enhancing Technology to Improve Medication Adherence

Have you ever stopped taking your medication before your treatment was complete, or have you ever just forgotten to take your medication? While it's probably not intentional, 20 to 30 percent of prescriptions written are never filled by patients. In ...

Fri, Jan 23, 2015

Avella Ranks Extremely High in Patient Satisfaction According to Third-Party Research

We are excited to announce the results of our latest patient satisfaction survey. More than 95% of Avella’s customers rate their experience with the specialty pharmacy as “excellent” or “very good” according to third-party validated data. Avella’s ...

Fri, Jan 2, 2015

How Technology is Transforming the Specialty Pharmacy Industry

How innovative software, systems and mobile applications are empowering physicians and engaging patients. This article was originally published in Dispensing Excellence, a publication by Avella Specialty Pharmacy.

Fri, Dec 5, 2014

5 Biggest Challenges for Stakeholders in the Oncology Value Chain

In 2014, Rebecca M. Shanahan was named Chief Executive Officer of Avella Specialty Pharmacy, after serving three years on the company’s board of directors. The following interview was conducted with Ms. Shanahan for the Institute for International ...

Mon, Oct 13, 2014

Avella Proud to Fulfill HARVONI™ for Hepatitis C Patients

A breakthrough treatment for hepatitis C genotype 1 is here. Avella is proud to fulfill HARVONI™ in treating hepatitis C patients. HARVONI™ is a fixed-dose combination of ledipasvir, a hepatitis C virus (HCV) NS5A inhibitor, and sofosbuvir, an HCV ...

Fri, Oct 3, 2014

National Psoriasis Foundation Provides Valuable Resources for Dermatology Patients

Avella is proud to introduce the National Psoriasis Foundation as a valuable dermatology resource for our patients and providers. Founded in 1968, the National Psoriasis Foundation has evolved to become the leading patient advocacy group for the 7.5 ...

Sat, Sep 13, 2014

4 Ways to Show Your Support for Blood Cancer Awareness Month

Every September, The Leukemia & Lymphoma Society observes Blood Cancer Awareness Month. LLS does this as a unique way to raise awareness about blood cancers and the work LLS is doing to advance research to find cures and provide access to ...

Wed, Sep 10, 2014

Case Study: Significantly Improve Medication Non-Adherence with Behavioral Adherence Contracts

Medication non-adherence is a serious, widespread issue that impacts clinical outcomes and contributes to rising healthcare costs. In fact, 20-30% of prescriptions written are never filled by patients and around half of all medications for chronic ...